Bukwang Pharmaceutical Co., Ltd.

KOSE:A003000 株式レポート

時価総額:₩338.2b

Bukwang Pharmaceutical 過去の業績

過去 基準チェック /06

Bukwang Pharmaceutical's earnings have been declining at an average annual rate of -65.7%, while the Pharmaceuticals industry saw earnings growing at 11.7% annually. Revenues have been declining at an average rate of 3.5% per year.

主要情報

-65.7%

収益成長率

-65.8%

EPS成長率

Pharmaceuticals 業界の成長11.3%
収益成長率-3.5%
株主資本利益率-14.8%
ネット・マージン-27.1%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?

May 22
Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?

Investors In Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Should Consider This, First

Apr 03
Investors In Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Should Consider This, First

Did Bukwang Pharmaceutical's (KRX:003000) Share Price Deserve to Gain 71%?

Mar 08
Did Bukwang Pharmaceutical's (KRX:003000) Share Price Deserve to Gain 71%?

Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?

Feb 10
Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?

How Much Of Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Do Insiders Own?

Jan 14
How Much Of Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Do Insiders Own?

Does It Make Sense To Buy Bukwang Pharmaceutical Co., Ltd. (KRX:003000) For Its Yield?

Dec 19
Does It Make Sense To Buy Bukwang Pharmaceutical Co., Ltd. (KRX:003000) For Its Yield?

Did You Miss Bukwang Pharmaceutical's (KRX:003000) 90% Share Price Gain?

Nov 23
Did You Miss Bukwang Pharmaceutical's (KRX:003000) 90% Share Price Gain?

収支内訳

Bukwang Pharmaceutical の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

KOSE:A003000 収益、費用、利益 ( )KRW Millions
日付収益収益G+A経費研究開発費
30 Jun 24116,583-31,55142,68333,877
31 Mar 24123,087-28,33641,24334,601
31 Dec 23125,928-31,33046,37734,551
30 Sep 23162,391-19,77355,08827,225
30 Jun 23191,782-4,35555,17725,270
31 Mar 23191,230-5,25955,47925,328
31 Dec 22190,909-2,47552,69824,274
30 Sep 22183,371-1,32648,02923,960
30 Jun 22181,5522546,77521,422
31 Mar 22182,54817945,96120,619
31 Dec 21182,491-91745,17022,465
30 Sep 21178,012-4,38046,03223,753
30 Jun 21170,537-11,19445,54322,783
31 Mar 21168,711-9,47545,80220,664
31 Dec 20169,660-7,20346,63618,032
30 Sep 20171,57914048,75116,618
30 Jun 20170,9692,81752,69317,873
31 Mar 20170,116-11,05754,23317,070
31 Dec 19168,194-7,41254,19317,312
30 Sep 19158,981-17,45751,10119,919
30 Jun 19195,507129,92652,55421,421
31 Mar 19194,863144,87452,67723,822
31 Dec 18194,224145,67052,65024,640
30 Sep 18191,641150,19151,78224,972
30 Jun 18153,7319,50146,07723,748
31 Mar 18152,1208,87845,44426,767
31 Dec 17150,74311,09145,56725,067
30 Sep 17144,3068,09347,38322,041
30 Jun 17140,6754,06749,27122,520
31 Mar 17139,5786,66446,94417,485
31 Dec 16138,61815,80746,40818,677
30 Sep 16143,16222,75735,33928,532
30 Jun 16144,39033,64032,54227,118
31 Mar 16141,97533,89144,17616,954
31 Dec 15142,13225,13942,60714,879
30 Sep 15139,54325,35653,4863,251
30 Jun 15139,19721,73652,5361,928
31 Mar 15138,95622,78338,48912,874
31 Dec 14141,68723,61640,49710,229
30 Sep 14139,68122,98138,5578,943
30 Jun 14136,85723,00137,3117,979
31 Mar 14133,48422,33136,1517,242
31 Dec 13130,79519,53238,1607,242

質の高い収益: A003000 is currently unprofitable.

利益率の向上: A003000 is currently unprofitable.


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: A003000 is unprofitable, and losses have increased over the past 5 years at a rate of 65.7% per year.

成長の加速: Unable to compare A003000's earnings growth over the past year to its 5-year average as it is currently unprofitable

収益対業界: A003000 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (21.9%).


株主資本利益率

高いROE: A003000 has a negative Return on Equity (-14.82%), as it is currently unprofitable.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘